ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Genzyme Corp. - Genzyme Corp. Common Stock (MM)

Genzyme Corp. - Genzyme Corp. Common Stock (MM) (GENZ)

76,25
0,00
(0,00%)
Fermé 13 Décembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
76,25
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
76,25
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

GENZ Dernières nouvelles

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation -- Company Announces Four-Day Subsequent Offer Period for Remaining Shareholders -- Genzyme Becomes a Subsidiary of...

Standard & Poor's Announces Change to U.S. Index

Standard & Poor's Announces Change to U.S. Index PR Newswire NEW YORK, March 29, 2011 NEW YORK, March 29, 2011 /PRNewswire/ -- BlackRock Inc. (NYSE: BLK) will replace Genzyme Corp. (NASD: GENZ...

Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares

Genzyme Corporation (NASDAQ: GENZ) announced today that its Board of Directors unanimously recommends that Genzyme shareholders accept the sanofi-aventis revised tender offer...

Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group

Genzyme Corporation (Nasdaq: GENZ) today announced that it has completed the sale of its pharmaceutical intermediates business to International Chemical Investors Group...

Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Genzyme Corporation (NASDAQ: GENZ) today recognized International Rare Disease Day with the launch of a new program, the Genzyme Patient Advocacy Leadership Awards (PAL...

Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across A...

Genzyme Corporation (NASDAQ: GENZ) today announced three-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for...

Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year

Genzyme Corp. (NASDAQ: GENZ) today reported fourth-quarter 2010 results that reflect increasing supplies of Cerezyme® (imiglucerase for injection) and Fabrazyme® (agalsidase...

Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right

Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right Combination will enhance sanofi-aventis' sustainable growth strategy by expanding its...

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right -- Combination will enhance sanofi-aventis' sustainable growth strategy by expanding its footprint in...

Zacks Analyst Blog Highlights: Laboratory Corporation of America Holdings, Genzyme, Quest Diagnostics, Penn Virginia Resource Pa

Zacks Analyst Blog Highlights: Laboratory Corporation of America Holdings, Genzyme, Quest Diagnostics, Penn Virginia Resource Partners L.P. and Cloud Peak Energy PR Newswire CHICAGO, Feb. 11...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SHOTWSafety Shot Inc
US$ 0,25
(79,21%)
28,01k
PALIPalisade Bio Inc
US$ 2,36
(68,57%)
67,27M
LAESSEALSQ Corporation
US$ 1,8401
(60,01%)
250,63M
HIMXHimax Technologies Inc
US$ 9,73
(45,22%)
20,05M
TRVITrevi Therapeutics Inc
US$ 3,60
(44,58%)
63,49M
SPGCSacks Parente Golf Inc
US$ 0,3621
(-74,14%)
29,54M
KROSKeros Therapeutics Inc
US$ 18,40
(-73,20%)
14,41M
TFFPTFF Pharmaceuticals Inc
US$ 0,0657
(-59,62%)
13,24M
SFHGSamfine Creation Holdings Group Ltd
US$ 1,27
(-58,36%)
7,1M
APVOAptevo Therapeutics Inc
US$ 5,60
(-44,06%)
6,31M
GOEVCanoo Inc
US$ 0,1737
(33,62%)
970,16M
LAESSEALSQ Corporation
US$ 1,8401
(60,01%)
250,63M
RGTIRigetti Computing Inc
US$ 5,9591
(-19,25%)
155,52M
NVDANVIDIA Corporation
US$ 137,34
(-1,41%)
154,89M
CDTConduit Pharmaceuticals Inc
US$ 0,0798
(-9,63%)
118,16M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock